The market shifted hard in early 2026. After Novo Nordisk reached a settlement in March, a wave of telehealth brands quietly dropped their compounded semaglutide programs and pivoted to branded prescriptions. At the same time, the FDA sent warning letters to more than 30 compounding telehealth firms. Then Lilly started selling oral orforglipron through LillyDirect at around $149 a month. In a few weeks, the whole competitive picture changed.
So I went back through nine options, compounded and branded, to figure out who actually holds up in 2026 and for which type of patient.
1. Mochi Health
Best overall for compounded GLP-1s, in my opinion. Mochi puts board-certified obesity-medicine physicians on your care team, not just a general practitioner checking a box. That matters when you’re managing dose escalation or dealing with side effects. Compounded semaglutide is priced at roughly $99 per month, tirzepatide at roughly $199. Those prices are genuinely competitive. The monitoring is heavier than most cash-pay services, which means more touchpoints but also more accountability. If you want clinical depth plus a low compounded price, this is where I’d start.
2. HealthRX
Strong second. HealthRX dispenses through Manifest Pharmacy in Greer, South Carolina, a 503A compounding pharmacy operating under USP-797 standards with lot tracking from production to delivery. That level of supply-chain transparency is rare at this price. Compounded semaglutide starts at $99 a month, tirzepatide at $149. Free overnight shipping to all 50 states. Your intake form goes to a board-certified physician who typically completes their review within 24 hours. LegitScript certified (cert 50087439).
The $149 tirzepatide entry price is notably lower than most competitors. Worth saying plainly: these are compounded medications, not FDA-approved branded drugs. The clinical trials HealthRX cites, roughly 15% body weight loss for semaglutide over 68 weeks (STEP 1) and about 21% for tirzepatide over 72 weeks (SURMOUNT-1), reflect the branded drug studies. Your results with a compound are your results.
3. FormBlends
The pick for someone who wants published purity data or needs more than just GLP-1s. FormBlends posts actual third-party test results per vial, including HPLC purity percentages, mass spec identity confirmation, and endotoxin sterility results. Most telehealth providers say “pharmacy-grade” and leave it there. FormBlends shows the numbers. Compounded semaglutide is around $299 per vial, tirzepatide around $349. Higher than HealthRX’s entry pricing, no question. But if documentation matters to you, that premium buys something real.
FormBlends also carries a broader catalog of peptides covering recovery, longevity, and cognitive support, all under the same physician oversight model. Ships to 47 states. If you want GLP-1s and BPC-157 or other peptides from a single provider with clinician sign-off, this is the only option on this list that does it.
4. Hims & Hers
They exited compounded GLP-1s after the March 2026 Novo settlement and moved fully to branded medications. Injectable Wegovy is now around $299 a month through their platform, oral options around $249, and Zepbound around $399. With insurance and a manufacturer savings card, costs can reportedly drop to $0 to $25. If you have insurance coverage or qualify for assistance programs, Hims & Hers has the infrastructure to help you work that angle. Not for cash-pay patients without coverage.
5. Ro Body
Ro charges about $39 for the first month, then $74 to $149 per month for the platform. Medications bill separately. They have a prior-authorization team specifically to fight insurance denials for branded GLP-1s, which is genuinely useful and not something every telehealth brand bothers to staff. If your goal is Wegovy or Zepbound covered by insurance, Ro’s team may earn their fee.
6. PlushCare
Membership is $19.99 a month. They offer same-day appointments, branded medications, and actual insurance billing. For people who already have a GLP-1 covered by insurance and just need a telehealth prescription pathway, PlushCare is one of the cheaper monthly access fees on this list. Straightforward, no frills.
7. Henry Meds
Cash-pay compounded service, no insurance. First month runs around $179 to $249, with fast shipping, often within 24 to 72 hours. Monitoring is lighter than Mochi or Form Health, which lowers the overhead but also means less clinical hand-holding. Good fit for someone who has already been on a GLP-1 before and knows what they’re doing.
8. Found
About $99 a month for the platform, medications billed separately. Found combines prescription access with coaching, behavioral support, and tools for tracking habits alongside the medication. It sits in a middle tier, not as medically intensive as Calibrate or Form Health, but more structured than a pure prescription service. Reasonable option if the coaching component actually appeals to you.
9. Form Health
Premium tier. Around $299 a month, and that gets you a physician plus a registered dietitian working together on your case, along with labs included. Medication costs are separate. Form Health is the most clinically intensive option on this list. It is also the most expensive. If you’ve failed simpler programs before and want genuine medical supervision rather than a monthly check-in, the cost may be justified. Not the right call for someone just starting out who wants to test whether a GLP-1 works for them.
How I’d Break This Down
| Provider | Type | Starting Price | Ships To | Good For |
| Mochi Health | Compounded | ~$99/mo sema | Wide | Clinical depth + low price |
| HealthRX | Compounded | ~$99/mo sema | All 50 states | Price, pharmacy transparency |
| FormBlends | Compounded | ~$299/vial sema | 47 states | Purity docs + peptide catalog |
| Hims & Hers | Branded | ~$299/mo | Wide | Insurance coverage pathways |
| Ro Body | Branded | ~$39 first mo | Wide | Prior-auth insurance support |
| PlushCare | Branded | ~$19.99/mo | Wide | Low-fee insurance access |
| Henry Meds | Compounded | ~$179 mo one | Wide | Fast ship, minimal monitoring |
| Found | Compounded/Branded | ~$99/mo | Wide | Coaching + prescription combo |
| Form Health | Branded/Supervised | ~$299/mo | Wide | Maximum clinical oversight |
One thing worth saying: the FDA warning letters sent to compounding firms in early 2026 were real, and they matter. Before committing to any compounded GLP-1 provider, check that their pharmacy is verifiably 503A-compliant, that testing documentation exists, and that the prescribing physician is actually licensed in your state.
Common Questions
What actually changed for compounded semaglutide after the March 2026 Novo Nordisk settlement?
The settlement confirmed that semaglutide is no longer on the FDA shortage list, which removed the legal basis most 503A pharmacies used to compound it at scale. Several telehealth platforms, including Hims & Hers, stopped offering compounded semaglutide entirely and shifted to branded Wegovy and Zepbound. Providers still offering compounded versions are operating in a narrower legal window and face higher regulatory scrutiny.
Is the weight loss data cited for compounded semaglutide and tirzepatide actually applicable to compounded versions?
No, not directly. The 15% body-weight-loss figure for semaglutide (STEP 1) and the 21% figure for tirzepatide (SURMOUNT-1) come from trials using Novo Nordisk’s Ozempic/Wegovy and Lilly’s Mounjaro/Zepbound. Compounded versions use the same active molecule but are not tested in the same trials. Purity, inactive ingredients, and dosing consistency can vary by pharmacy.
How does FormBlends’ per-vial pricing compare to the monthly pricing other services advertise?
FormBlends charges around $299 per vial for semaglutide versus the $99 per month entry price at Mochi Health or HealthRX. A single vial typically covers multiple doses across several weeks depending on your titration schedule, so the monthly equivalent cost may be closer than the headline numbers suggest. The real distinction is that FormBlends publishes HPLC purity data, which the $99 options do not.
If my insurance covers Wegovy or Zepbound, which platform on this list is best positioned to help me use that benefit?
Ro Body is the strongest option here. They staff a dedicated prior-authorization team specifically to contest insurance denials for branded GLP-1s, which is a meaningful operational difference. Hims & Hers also supports insurance and savings-card pathways. PlushCare bills insurance directly and has the lowest monthly platform fee at $19.99, making it a reasonable choice if your coverage is already confirmed and you mainly need prescription access.
What does 503A-compliant actually mean, and why does it matter when choosing a compounding pharmacy?
A 503A pharmacy compounds medications for individual patients under a valid prescription, operating under state board oversight and USP standards like USP-797 for sterile preparations. It is not the same as FDA drug approval. What it means practically: the pharmacy must follow specific sterility and quality protocols, and lot tracking from production to delivery, as HealthRX offers through Manifest Pharmacy, is one sign a 503A operation is taking those standards seriously.
Sources
- FDA: 503A Compounding Pharmacies guidance and 2026 warning letter announcements (FDA.gov)
- SURMOUNT-1 trial results, tirzepatide: Jastreboff et al., *New England Journal of Medicine*, 2022
- STEP 1 trial results, semaglutide: Wilding et al., *New England Journal of Medicine*, 2021
- LillyDirect orforglipron announcement, April 2026 (Eli Lilly press release)
- Novo Nordisk compounded semaglutide settlement, March 9, 2026 (Novo Nordisk press release)
- LegitScript pharmacy certification database (LegitScript.com)
